Concurrent cisplatin and 5-fluorouracil versus concurrent cisplatin and docetaxel with radiotherapy for esophageal squamous cell carcinoma: a propensity score-matched analysis-Reference-Cited by-同舟云学术

Concurrent cisplatin and 5-fluorouracil versus concurrent cisplatin and docetaxel with radiotherapy for esophageal squamous cell carcinoma: a propensity score-matched analysis

Published:2016-05-11 Issue:28 Volume:7 Page:44686-44694
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Zhang Peng¹²³,Xi Mian¹²³,Li Qiao-Qiao¹²³,Hu Yong-Hong¹²³,Guo Xiaobo⁴⁵,Zhao Lei¹²³,Liu Hui¹²³,Liu Shi-Liang¹²³,Luo Li-Ling¹²³,Liu Qing⁶,Liu Meng-Zhong¹²³

Affiliation:

1. Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China

2. Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, People's Republic of China

3. Guangdong Esophageal Cancer Research Institute, Guangzhou, Guangdong, People's Republic of China

4. Department of Statistical Science, School of Mathematics & Computational Science, Sun Yat-Sen University, Guangzhou, People's Republic of China

5. Department of Ophthalmology, University of Melbourne, Melbourne, Victoria, Australia

6. Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, Guangdong Province, People's Republic of China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Definitive concurrent chemoradiotherapy with docetaxel plus cisplatin versus 5-fluorouracil plus cisplatin in patients with esophageal squamous cell carcinoma: long-term follow-up results of a phase II randomized controlled trial;Radiation Oncology;2023-09-12

2. Phase I study of cisplatin and nanoparticle albumin‐bound‐paclitaxel combined with concurrent radiotherapy in locally advanced esophageal squamous cell carcinoma;Cancer Medicine;2023-06-19

3. Meta-analysis of the efficacy and toxicity of paclitaxel combined with platinum (PTX) and fluorouracil combined with cisplatin (PF) in the treatment of concurrent chemoradiotherapy (CCRT) for unresectable esophageal cancer;2023-02-03

4. Definitive Chemoradiotherapy for Esophageal Cancer;Esophageal Cancer;2023

5. Comparison of Efficacy and Safety of Taxanes Plus Platinum and Fluorouracil Plus Platinum in the First-Line Treatment of Esophageal Cancer: A Systematic Review and Meta-Analysis;Current Oncology;2022-09-16